OTCMKTS:AMBBY Ambu A/S (AMBBY) Stock Price, News & Analysis $15.35 0.00 (0.00%) As of 05/23/2025 Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesShort InterestBuy This Stock About Ambu A/S Stock (OTCMKTS:AMBBY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Ambu A/S alerts:Sign Up Key Stats Today's Range$15.35▼$15.3550-Day Range$15.19▼$18.0552-Week Range$13.02▼$22.65VolumeN/AAverage Volume603 shsMarket Capitalization$3.61 billionP/E Ratio90.29Dividend Yield0.13%Price TargetN/AConsensus RatingStrong Buy Company OverviewAmbu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark.Read More… Receive AMBBY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ambu A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address AMBBY Stock News HeadlinesEuropean Growth Companies With High Insider Ownership For May 2025May 15, 2025 | finance.yahoo.comEuropean Growth Stocks Insiders Are Investing InApril 16, 2025 | finance.yahoo.comTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.” We recently sat down with Rickards to capture all the key details on tape. May 24, 2025 | Paradigm Press (Ad)European Value Stocks That May Be Priced Below Intrinsic Estimates In April 2025April 10, 2025 | finance.yahoo.com3 European Growth Companies With Insider Ownership Up To 26%March 18, 2025 | finance.yahoo.com3 Growth Stocks Insiders Own With Up To 39% Earnings GrowthFebruary 15, 2025 | uk.finance.yahoo.comAmbu A/S goes ex dividend tomorrowDecember 6, 2024 | msn.comAmbu A/S (AMBBY)December 5, 2024 | finance.yahoo.comSee More Headlines AMBBY Stock Analysis - Frequently Asked Questions How have AMBBY shares performed this year? Ambu A/S's stock was trading at $13.02 at the beginning of 2025. Since then, AMBBY stock has increased by 17.9% and is now trading at $15.35. View the best growth stocks for 2025 here. How were Ambu A/S's earnings last quarter? Ambu A/S (OTCMKTS:AMBBY) released its earnings results on Wednesday, May, 7th. The company reported $0.10 EPS for the quarter. Ambu A/S had a trailing twelve-month return on equity of 5.67% and a net margin of 5.69%. How do I buy shares of Ambu A/S? Shares of AMBBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/07/2025Today5/24/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Holding & other investment offices Sub-IndustryN/A Current SymbolOTCMKTS:AMBBY Previous SymbolOTCMKTS:AMBBY CIKN/A Webwww.ambu.com Phone(457) 225-2000FaxN/AEmployees5,196Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.19 Trailing P/E Ratio90.29 Forward P/E RatioN/A P/E GrowthN/ANet Income$34.17 million Net Margins5.69% Pretax Margin5.56% Return on Equity5.67% Return on Assets4.46% Debt Debt-to-Equity Ratio0.08 Current Ratio2.60 Quick Ratio1.47 Sales & Book Value Annual Sales$783.76 million Price / Sales4.60 Cash Flow$0.45 per share Price / Cash Flow34.34 Book Value$3.46 per share Price / Book4.44Miscellaneous Outstanding Shares234,974,000Free FloatN/AMarket Cap$3.61 billion OptionableNot Optionable Beta1.45 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (OTCMKTS:AMBBY) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredMemorial Day Sale! 82% Off Disruptors and Dominators!Jensen Huang recently gave the keynote speech at the Consumer Electronics Show in Las Vegas. When the Nvidi...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ambu A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Ambu A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.